These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8004962)

  • 1. Is mesangial cell proliferation required for extracellular matrix expansion in glomerular disease?
    Eng E; Floege J; Young BA; Alpers CE; Couser WG; Johnson RJ
    Contrib Nephrol; 1994; 107():156-62. PubMed ID: 8004962
    [No Abstract]   [Full Text] [Related]  

  • 2. Does extracellular matrix expansion in glomerular disease require mesangial cell proliferation?
    Eng E; Floege J; Young BA; Couser WG; Johnson RJ
    Kidney Int Suppl; 1994 Feb; 45():S45-7. PubMed ID: 8158896
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor.
    Johnson RJ; Raines EW; Floege J; Yoshimura A; Pritzl P; Alpers C; Ross R
    J Exp Med; 1992 May; 175(5):1413-6. PubMed ID: 1569407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro.
    Pichler RH; Bassuk JA; Hugo C; Reed MJ; Eng E; Gordon KL; Pippin J; Alpers CE; Couser WG; Sage EH; Johnson RJ
    Am J Pathol; 1996 Apr; 148(4):1153-67. PubMed ID: 8644857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis.
    Hohenstein B; Daniel C; Wagner A; Stasch JP; Hugo C
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F685-93. PubMed ID: 15561976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of platelet-derived growth factor in glomerular disease.
    Johnson RJ; Floege J; Couser WG; Alpers CE
    J Am Soc Nephrol; 1993 Aug; 4(2):119-28. PubMed ID: 8311852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic compound (TNP-470) inhibits mesangial cell proliferation in vitro and in vivo.
    Haraguchi M; Okamura M; Konishi M; Konishi Y; Negoro N; Inoue T; Kanayama Y; Yoshikawa J
    Kidney Int; 1997 Jun; 51(6):1838-46. PubMed ID: 9186873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mesangial cells in glomerulosclerosis.
    Striker LJ; Doi T; Conti F; Striker GE
    J Diabet Complications; 1991; 5(2-3):60-1. PubMed ID: 1663117
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute glomerular upregulation of ornithine decarboxylase is not essential for mesangial cell proliferation and matrix expansion in anti-Thy-1-nephritis.
    Ketteler M; Westenfeld R; Gawlik A; de Heer E; Distler A
    Nephrol Dial Transplant; 2000 Jan; 15(1):16-22. PubMed ID: 10607762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroporation-mediated PDGF receptor-IgG chimera gene transfer ameliorates experimental glomerulonephritis.
    Nakamura H; Isaka Y; Tsujie M; Akagi Y; Sudo T; Ohno N; Imai E; Hori M
    Kidney Int; 2001 Jun; 59(6):2134-45. PubMed ID: 11380815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resident glomerular cells in glomerular injury: mesangial cells.
    Abboud HE
    Semin Nephrol; 1991 May; 11(3):304-11. PubMed ID: 2057645
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of platelet-derived growth factor in progression of nephropathy].
    Spustová V; Oksa A; Dzúrik R
    Vnitr Lek; 1996 Dec; 42(12):842-8. PubMed ID: 9072884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of experimental mesangial proliferative nephritis by interferon-gamma.
    Johnson RJ; Lombardi D; Eng E; Gordon K; Alpers CE; Pritzl P; Floege J; Young B; Pippin J; Couser WG
    Kidney Int; 1995 Jan; 47(1):62-9. PubMed ID: 7731171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesangial cell-matrix interactions in glomerular inflammation.
    Schoecklmann HO; Rupprecht HD; Gauer S; Yao J; Sterzel RB
    Kidney Blood Press Res; 1996; 19(3-4):184-90. PubMed ID: 8887258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor: a potentially important cytokine in glomerular disease.
    Johnson R; Iida H; Yoshimura A; Floege J; Bowen-Pope DF
    Kidney Int; 1992 Mar; 41(3):590-4. PubMed ID: 1573833
    [No Abstract]   [Full Text] [Related]  

  • 17. Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in Habu snake venom-induced glomerulonephritis.
    Barnes JL; Abboud HE
    Am J Pathol; 1993 Nov; 143(5):1366-76. PubMed ID: 8238253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
    Gilbert RE; Kelly DJ; McKay T; Chadban S; Hill PA; Cooper ME; Atkins RC; Nikolic-Paterson DJ
    Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.
    Floege J; Eng E; Young BA; Couser WG; Johnson RJ
    Kidney Int; 1993 Feb; 43(2):369-80. PubMed ID: 8441232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo.
    Daniel C; Wiede J; Krutzsch HC; Ribeiro SM; Roberts DD; Murphy-Ullrich JE; Hugo C
    Kidney Int; 2004 Feb; 65(2):459-68. PubMed ID: 14717916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.